| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Sam Norton | Q47557865 |
| Jonathan C Tosh | Q37842020 | ||
| Suzanne Verstappen | Q42677144 | ||
| Deborah P.M. Symmons | Q54100237 | ||
| Rebecca Davies | Q57058689 | ||
| Allan Wailoo | Q90186791 | ||
| P2093 | author name string | Bo Fu | |
| David L Scott | |||
| Adam Young | |||
| Mark Lunt | |||
| Chris Deighton | |||
| P2860 | cites work | Percentile benchmarks in patients with rheumatoid arthritis: Health Assessment Questionnaire as a quality indicator (QI) | Q24798309 |
| Predictors of disability in a longitudinal sample of patients with rheumatoid arthritis | Q33567552 | ||
| The links between joint damage and disability in rheumatoid arthritis | Q33867923 | ||
| The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study | Q33923245 | ||
| Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis. | Q34081871 | ||
| Marital status and the progression of functional disability in patients with rheumatoid arthritis | Q46576308 | ||
| Severity of rheumatoid arthritis: the SEVERA study. | Q47233433 | ||
| Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis | Q47317958 | ||
| The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. | Q50602102 | ||
| The impact of low family income on self-reported health outcomes in patients with rheumatoid arthritis within a publicly funded health-care environment. | Q50747195 | ||
| Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. | Q50747871 | ||
| Anti-cyclic citrullinated peptide antibody predicts functional disability in patients with rheumatoid arthritis in a large prospective observational cohort in Japan. | Q51155261 | ||
| Social support and psychological distress in rheumatoid arthritis: a 4-year prospective study. | Q51171340 | ||
| Health-related quality of life and continuation rate on first-line anti-tumour necrosis factor therapy among rheumatoid arthritis patients from the Australian Rheumatology Association Database | Q51650310 | ||
| Elevation of serum matrix metalloproteinase-3 as a predictive marker for the long-term disability of rheumatoid arthritis patients in a prospective observational cohort IORRA. | Q51733238 | ||
| The development of emotional distress in 158 patients with recently diagnosed rheumatoid arthritis: a prospective 5-year follow-up study. | Q51842611 | ||
| A prognostic model for functional outcome in early rheumatoid arthritis. | Q51938017 | ||
| Treatment and nontreatment predictors of health assessment questionnaire disability progression in rheumatoid arthritis: a longitudinal study of 18,485 patients | Q34618811 | ||
| Determinants of physical function in rheumatoid arthritis: association with the disease process | Q35158475 | ||
| Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study | Q35547691 | ||
| No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset | Q35549071 | ||
| Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS). | Q35551485 | ||
| Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population | Q35554061 | ||
| MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years | Q35554101 | ||
| Joint damage and disability in rheumatoid arthritis: an updated systematic review | Q35669577 | ||
| Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register. | Q35760080 | ||
| Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys | Q35799592 | ||
| Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis | Q35954648 | ||
| Association of functional outcome with both personal- and area-level socioeconomic inequalities in patients with inflammatory polyarthritis | Q36388001 | ||
| Differences in activity limitation, pain intensity, and global health in patients with rheumatoid arthritis in Sweden and the USA: a 5-year follow-up | Q36725890 | ||
| Measuring disability and quality of life in established rheumatoid arthritis | Q36942633 | ||
| Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study | Q36993230 | ||
| Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort | Q37129582 | ||
| Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA database. | Q37365479 | ||
| The economics of treatment in early rheumatoid arthritis | Q37398090 | ||
| The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review | Q37962891 | ||
| Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998:a longitudinal study of 3035 patients | Q38482066 | ||
| Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects | Q40639319 | ||
| One year followup variables predict disability 5 years after presentation with inflammatory polyarthritis with greater accuracy than at baseline | Q40743103 | ||
| How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS) | Q40757933 | ||
| Short-term outcomes in recent-onset rheumatoid arthritis. | Q40931442 | ||
| Functional disability in rheumatoid arthritis: two different models in early and established disease | Q41117731 | ||
| Patients with rheumatoid arthritis in clinical care | Q41828498 | ||
| Effect of Parenterally Administered Gold Therapy on the Course of Adult Rheumatoid Arthritis | Q41905854 | ||
| Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use | Q41943300 | ||
| The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis | Q42661052 | ||
| Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis | Q43463510 | ||
| Do patients with elderly-onset rheumatoid arthritis have severe functional disability? | Q44211778 | ||
| Trajectories of functional limitation in early rheumatoid arthritis and their association with mortality. | Q44322915 | ||
| The assessment and prediction of functional disability in rheumatoid arthritis. | Q44405917 | ||
| Clinical and health status measures over time: prognosis and outcome assessment in rheumatoid arthritis | Q44533024 | ||
| Low disease activity state with corticosteroid may not represent 'true' low disease activity state in patients with rheumatoid arthritis | Q45341957 | ||
| The influence of sex on patients with rheumatoid arthritis in a large observational cohort | Q46349860 | ||
| Associations between demographic and disease-related variables and disability over the first five years of inflammatory polyarthritis: a longitudinal analysis using generalized estimating equations. | Q52072835 | ||
| Analyzing developmental trajectories of distinct but related behaviors: a group-based method. | Q52137299 | ||
| Tobit, fixed effects, and cohort analyses of the relationship between severity and duration of rheumatoid arthritis. | Q52886419 | ||
| STANFORD HEALTH ASSESSMENT QUESTIONNAIRE MODIFIED TO ASSESS DISABILITY IN BRITISH PATIENTS WITH RHEUMATOID ARTHRITIS | Q61912680 | ||
| A reappraisal of HAQ disability in rheumatoid arthritis | Q64112218 | ||
| Severity of disability and duration of disease in rheumatoid arthritis | Q67823605 | ||
| Sensitivity to change of the health assessment questionnaire (HAQ) and other clinical and health status measures in rheumatoid arthritis: results of short-term clinical trials and observational studies versus long-term observational studies | Q67958014 | ||
| The effect of age on methotrexate efficacy and toxicity | Q68014115 | ||
| The development of disability in rheumatoid arthritis | Q69506380 | ||
| Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study | Q70211047 | ||
| The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales | Q70606503 | ||
| Percentile curve reference charts of physical function: rheumatoid arthritis population | Q71750900 | ||
| Functional disability in early rheumatoid arthritis: description and risk factors | Q72731696 | ||
| An evaluation of the Health Assessment Questionnaire in long-term longitudinal follow-up of disability in rheumatoid arthritis | Q72872862 | ||
| Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time | Q73065125 | ||
| Longterm health outcomes of patients with rheumatoid arthritis treated in managed care and fee-for-service practice settings | Q74477379 | ||
| A 10 year prospective followup of patients with rheumatoid arthritis 1986-96 | Q77170087 | ||
| Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs | Q77170095 | ||
| Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population | Q79158406 | ||
| Are there more than cross-sectional relationships of social support and support networks with functional limitations and psychological distress in early rheumatoid arthritis? the European Research on Incapacitating Diseases and Social Support Longit | Q80848328 | ||
| Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes | Q82696663 | ||
| Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage | Q83213425 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported | Q15643954 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | disability | Q12131 |
| rheumatoid arthritis | Q187255 | ||
| questionnaire | Q747810 | ||
| systematic review | Q1504425 | ||
| patient outcome assessment | Q65494848 | ||
| biomedical investigative technique | Q66648976 | ||
| disease progression | Q86758334 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 131-144 | |
| P577 | publication date | 2014-05-09 | |
| 2014-10-01 | |||
| P1433 | published in | Seminars in Arthritis and Rheumatism | Q15761553 |
| P1476 | title | Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts | |
| P478 | volume | 44 |
| Q90354326 | A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis - results of clinical relevance |
| Q57167038 | Associations between fatigue and physical capacity in people moderately affected by rheumatoid arthritis |
| Q64916954 | Baseline patient reported outcomes are more consistent predictors of long-term functional disability than laboratory, imaging or joint count data in patients with early inflammatory arthritis: A systematic review. |
| Q31148620 | Discordant inflammation and pain in early and established rheumatoid arthritis: Latent Class Analysis of Early Rheumatoid Arthritis Network and British Society for Rheumatology Biologics Register data. |
| Q36332275 | Doubly robust estimation of generalized partial linear models for longitudinal data with dropouts |
| Q41544298 | Functional limitations in the phase of clinically suspect arthralgia are as serious as in early clinical arthritis; a longitudinal study |
| Q53075102 | General and disease-specific pain trajectories as predictors of social and political outcomes in arthritis and cancer. |
| Q53745420 | Health assessment questionnaire-disability index (HAQ-DI) score at the start of biological disease-modifying antirheumatic drug (bDMARD) therapy is associated with radiographic progression of large joint damage in patients with rheumatoid arthritis. |
| Q35753598 | Heterogeneous Disease Trajectories Explain Variable Radiographic, Function and Quality of Life Outcomes in the Canadian Early Arthritis Cohort (CATCH). |
| Q92628095 | Impact of the combined presence of erosions and ACPA on rheumatoid arthritis disease activity over time: results from the METEOR registry |
| Q59151101 | Interpretation of DAS28 and its components in the assessment of inflammatory and non-inflammatory aspects of rheumatoid arthritis |
| Q90564068 | Investigating musculoskeletal health and wellbeing; a cohort study protocol |
| Q38803211 | Latent classes of resilience and psychological response among only-child loss parents in China |
| Q64981488 | Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity. |
| Q92464711 | Pain, sleep and emotional well-being explain the lack of agreement between physician- and patient-perceived remission in early rheumatoid arthritis |
| Q55655944 | Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS). |
| Q61772924 | Sarilumab for Previously-Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal |
| Q38843514 | Semi-varying coefficient multinomial logistic regression for disease progression risk prediction |
| Q88076637 | Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology Appraisal |
| Q35842618 | Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters |
Search more.